Ivonescimab Extends Overall Survival in Advanced Squamous Non-Small Cell Lung Cancer
A randomized phase 3 trial demonstrated an overall survival benefit with ivonescimab plus chemotherapy over tislelizumab plus chemotherapy in untreated ...
A randomized phase 3 trial demonstrated an overall survival benefit with ivonescimab plus chemotherapy over tislelizumab plus chemotherapy in untreated ...
A retrospective study in Nepal found that an ultra-low-dose nivolumab regimen achieved a 53.51 percent response rate in patients with ...
Researchers have discovered that ZNF292 gene mutations disrupt protein synthesis, impair cellular responses to replication stress, and identify an adverse ...
A systematic review and meta-analysis indicates that dual checkpoint inhibition with nivolumab and ipilimumab improves efficacy outcomes in advanced cancers ...
A retrospective study of 1,140 patients who underwent radical gastrectomy found that while post-recurrence survival varied across initial metastatic patterns, ...
Ablating autocrine CCL2 signaling in medulloblastoma cells disrupts multiple oncogenic pathways and reveals an eight-gene expression signature strongly tied to ...
A retrospective cohort study found that consolidative stem cell transplantation was associated with improved survival in pediatric leukemia patients achieving ...
A retrospective cohort study found that adding surufatinib and camrelizumab to standard chemotherapy boosted response rates in metastatic pancreatic cancer ...
A systematic review and meta-analysis indicates that sleeve lobectomy is associated with improved long-term survival and reduced early mortality compared ...
A retrospective study from an Egyptian cancer center associated the introduction of targeted anti-HER-2 therapy with higher response rates and ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine